Jesse E Merten sold $7.1M of ALL
EVP & Chief Financial Officer at ALLSTATE CORP. 33,986 shares at an average of $208.57, traded Feb 25, 2026, filed Feb 26, 2026.
Score components
- +8RoleOther
- +25Trade size$7.1M at market
- +20Share of holdings soldSold 51% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -4.2%, 3m -2.1%, 6m +22.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000899051-26-000051, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | MOption exercise Common Stock10b5-1 | +1,201 | $0.00 | $0 | 32,834 | Feb 26, 2026 |
| Feb 24, 2026 | FTax withholding Common Stock10b5-1 | -533 | $209.82 | $112k | 32,301 | Feb 26, 2026 |
| Feb 25, 2026 | MOption exercise Common Stock10b5-1 | +12,879 | $122.64 | $1.6M | 45,180 | Feb 26, 2026 |
| Feb 25, 2026 | MOption exercise Common Stock10b5-1 | +1,734 | $133.00 | $231k | 46,914 | Feb 26, 2026 |
| Feb 25, 2026 | MOption exercise Common Stock10b5-1 | +19,373 | $137.10 | $2.7M | 66,287 | Feb 26, 2026 |
| Feb 25, 2026 | SOpen-market sale Common Stock10b5-1 | -8,811 | $207.53 | $1.8M | 57,476 | Feb 26, 2026 |
| Feb 25, 2026 | SOpen-market sale Common Stock10b5-1 | -15,893 | $208.58 | $3.3M | 41,583 | Feb 26, 2026 |
| Feb 25, 2026 | SOpen-market sale Common Stock10b5-1 | -7,982 | $209.40 | $1.7M | 33,601 | Feb 26, 2026 |
| Feb 25, 2026 | SOpen-market sale Common Stock10b5-1 | -1,300 | $210.44 | $274k | 32,301 | Feb 26, 2026 |
| Feb 24, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -1,201 | $0.00 | $0 | 2,402 | Feb 26, 2026 |
| Feb 25, 2026 | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -12,879 | $0.00 | $0 | 0 | Feb 26, 2026 |
| Feb 25, 2026 | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -1,734 | $0.00 | $0 | 868 | Feb 26, 2026 |
| Feb 25, 2026 | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -19,373 | $0.00 | $0 | 9,687 | Feb 26, 2026 |
Related signals
Other insiders at ALLSTATE CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | ALLSTATE CORP | Mario Rizzo other | $15M 56,225 shares | -41% | |
| 61Notable | ALLSTATE CORP | John E Dugenske Chief Financial Officer | $8.9M 32,996 shares | -72% | |
| 45Moderate | ALLSTATE CORP | Andrea Redmond director | $451k 2,225 shares | -100% | |
| 16Weak | ALLSTATE CORP | Mark Q Prindiville other | $335k 1,550 shares | -5% | |
| 23Weak | ALLsell ALLSTATE CORP | Mario Rizzo other | $4.1M 18,578 shares | -18% | |
| 35Weak | ALLSTATE CORP | Thomas J Wilson Chairman, President & CEO | $3.5M 16,807 shares | -18% | |
| 43Moderate | ALLSTATE CORP | Thomas J Wilson Chairman, President & CEO | $3.6M 16,807 shares | -15% | |
| 43Moderate | ALLSTATE CORP | Thomas J Wilson Chairman, President & CEO | $3.5M 16,807 shares | -13% | |
| 35Weak | ALLSTATE CORP | Thomas J Wilson Chairman, President & CEO | $3.4M 16,807 shares | -18% | |
| 43Moderate | ALLSTATE CORP | Thomas J Wilson Chairman, President & CEO | $3.5M 16,807 shares | -15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.